XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2006-05-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.0601938103PMID 16670198PMCID PMC1464348
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent advances in embryonal tumours of the central nervous system

  2005cited by this paper
• Differentiation of classic medulloblastoma into metastatic large cell medulloblastoma with focal rhabdoid differentiation in the absence of posterior fossa recurrence

  2005cited by this paper
• Medulloblastoma: developmental mechanisms out of control.

  2005cited by this paper
• The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.

  2005cited by this paper
• Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.

  2004cited by this paper
• The cellular response to general and programmed DNA double strand breaks.

  2004cited by this paper
• The role of the non‐homologous end‐joining pathway in lymphocyte development

  2004cited by this paper
• Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.

  2003cited by this paper
• A molecular fingerprint for medulloblastoma.

  2003cited by this paper
• Transcriptional profiling of medulloblastoma in children.

  2003cited by this paper
• Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors

  2003cited by this paper
• H2AX haploinsufficiency modifies genomic stability and tumor susceptibility.

  2003cited by this paper
• Conditional Mutation of Rb Causes Cell Cycle Defects without Apoptosis in the Central Nervous System

  2003cited by this paper
• Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors.

  2003cited by this paper
• N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation.

  2002cited by this paper
• DNA ligase IV suppresses medulloblastoma formation.

  2002cited by this paper
• Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations.

  2002cited by this paper
• Jumping translocations are common in solid tumor cell lines and result in recurrent fusions of whole chromosome arms

  2001cited by this paper
• 1-Class Integrins Regulate the Development of Laminae and Folia in the Cerebral and Cerebellar Cortex

  2001cited by this paper
• Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched.

  2001cited by this paper
• Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions.

  2001cited by this paper
• Chromosomal variation in neurons of the developing and adult mammalian nervous system

  2001cited by this paper
• DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.

  2000cited by this paper
• Defective embryonic neurogenesis in Ku-deficient but not DNA-dependent protein kinase catalytic subunit-deficient mice.

  2000cited by this paper
• Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development

  2000cited by this paper
• Oncogene amplification in solid tumors.

  1999cited by this paper
• Human Neural Stem Cells: Isolation, Expansion and Transplantation

  1999cited by this paper
• A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis.

  1998cited by this paper
• Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

  1992cited by this paper
• Production of homozygous mutant ES cells with a single targeting construct

  1992cited by this paper
• Activated expression of the N-myc gene in human neuroblastomas and related tumors.

  1984cited by this paper
• Transposition and amplification of oncogene-related sequences in human neuroblastomas.

  1983cited by this paper

• Polymerase theta repairs persistent G1-induced DNA breaks in S-phase during class switch recombination

  2025cites this paper
• Current advances in the role of classical non‐homologous end joining in hematologic malignancies

  2025cites this paper
• Endogenous neuronal DNA double-strand breaks are not sufficient to drive brain aging and neurodegeneration

  2024cites this paper
• X-ray cross-complementing family: the bridge linking DNA damage repair and cancer

  2023cites this paper
• The Multiple Faces of the MRN Complex: Roles in Medulloblastoma and Beyond

  2023cites this paper
• Simultaneous Nbs1 and p53 inactivation in neural progenitors triggers high‐grade gliomas

  2023cites this paper
• Oocyte Vitrification Reduces its Capability to Repair Sperm DNA Fragmentation and Impairs Embryonic Development

  2023cites this paper
• A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma

  2022cites this paper
• SHLD1 is dispensable for 53BP1-dependent V(D)J recombination but critical for productive class switch recombination

  2022cites this paper
• Transcription-associated DNA DSBs activate p53 during hiPSC-based neurogenesis

  2022cites this paper
• The origin of unwanted editing byproducts in gene editing

  2022cites this paper
• Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges

  2022cites this paper
• Chromothripsis, DNA repair and checkpoints defects.

  2021cites this paper
• Deconstructing Sonic Hedgehog Medulloblastoma: Molecular Subtypes, Drivers, and Beyond.

  2020cites this paper
• Loss of H3K36 Methyltransferase SETD2 Impairs V(D)J Recombination during Lymphoid Development

  2020cites this paper
• Differential expression of DNA-dependent protein kinase catalytic subunit in the brain of neonatal mice and young adult mice

  2020cites this paper
• DNA-PK in human malignant disorders: Mechanisms and implications for pharmacological interventions.

  2020cites this paper
• The recent advances in non-homologous end-joining through the lens of lymphocyte development.

  2020cites this paper
• Protective Mechanisms Against DNA Replication Stress in the Nervous System

  2020cites this paper
• Modeling pediatric medulloblastoma

  2019cites this paper
• Drosophila p53 directs nonapoptotic programs in postmitotic tissue

  2019cites this paper
• The nucleoskeleton protein IFFO1 immobilizes broken DNA and suppresses chromosome translocation during tumorigenesis

  2019cites this paper
• DNA damage in aging, the stem cell perspective

  2019cites this paper
• Cancer risk from low dose radiation in Ptch1+/- mice with inactive DNA repair systems: Therapeutic implications for medulloblastoma.

  2019cites this paper
• Induction of recurrent break cluster genes in neural progenitor cells differentiated from embryonic stem cells in culture

  2019cites this paper
• Mediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF

  2019cites this paper
• RESOLUTION OF PROXIMAL OXIDATIVE BASE DAMAGE AND 3′-PHOSPHATE TERMINI FOR NONHOMOLOGOUS END JOINING OF FREE RADICAL-MEDIATED DNA DOUBLE-STRAND BREAKS

  2018cites this paper
• Rad51 recruitment and exclusion of non-homologous end joining during homologous recombination at a Tus/Ter mammalian replication fork barrier

  2018cites this paper
• Defective DNA damage repair leads to frequent catastrophic genomic events in murine and human tumors

  2018cites this paper
• Gain of function in the mouse model of a recurrent mutation p53N236S promotes the formation of double minute chromosomes and the oncogenic potential of p19ARF

  2018cites this paper
• DNA double-strand breaks as drivers of neural genomic change, function, and disease.

  2018cites this paper
• DNA polymerase β deficiency in the p53 null cerebellum leads to medulloblastoma formation.

  2018cites this paper
• The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer

  2017cites this paper
• Recurrently Breaking Genes in Neural Progenitors: Potential Roles of DNA Breaks in Neuronal Function, Degeneration and Cancer

  2017cites this paper
• Genome Editing in Neurosciences

  2017cites this paper
• Mechanism of tandem duplication formation in BRCA1 mutant cells

  2017cites this paper
• Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival

  2017cites this paper
• Non-homologous end-joining protein expression screen from radiosensitive cancer patients yields a novel DNA double strand break repair phenotype.

  2017cites this paper
• Synthetic lethality between murine DNA repair factors XLF and DNA-PKcs is rescued by inactivation of Ku70.

  2017cites this paper
• XRCC 4 rs 1805377 polymorphism increases glioma risk in Asian populations

  2016cites this paper
• Evasion of cell senescence in SHH medulloblastoma

  2016cites this paper
• Cerebellum Development and Tumorigenesis: A p53-Centric Perspective.

  2016cites this paper
• Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

  2016cites this paper
• Long Neural Genes Harbor Recurrent DNA Break Clusters in Neural Stem/Progenitor Cells.

  2016cites this paper
• Mechanisms of Recurrent Chromosomal Translocations

  2015cites this paper
• Medulloblastoma and CNS Primitive Neuroectodermal Tumors

  2015cites this paper
• Tumor-Initiating Cell Phenotype and Tumor Heterogeneity Epigenetic States of Cells of Origin and Tumor Evolution Drive

  2014cites this paper
• Reprint of "Functional overlaps between XLF and the ATM-dependent DNA double strand break response".

  2014cites this paper
• Functional overlaps between XLF and the ATM-dependent DNA double strand break response.

  2014cites this paper
• Epigenetic states of cells of origin and tumor evolution drive tumor-initiating cell phenotype and tumor heterogeneity.

  2014cites this paper
• Tumor and Stem Cell Biology EpigeneticStatesofCells ofOrigin andTumorEvolutionDrive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity

  2014cites this paper
• What underlies the diversity of brain tumors?

  2013cites this paper
• G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors

  2013cites this paper
• Molecular Genetics of Medulloblastoma

  2013cites this paper
• Animal Models of Brain Tumors

  2013cites this paper
• Fate Mapping for Activation-Induced Cytidine Deaminase (AID) Marks Non-Lymphoid Cells During Mouse Development

  2013cites this paper
• Functional redundancy between the XLF and DNA-PKcs DNA repair factors in V(D)J recombination and nonhomologous DNA end joining

  2013cites this paper
• Notch1-induced brain tumor models the sonic hedgehog subgroup of human medulloblastoma.

  2013cites this paper
• Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility

  2013cites this paper
• Role of nonhomologous end-joining in oral cancer and personalized pharmacogenomics

  2012cites this paper
• Matching mice to malignancy: molecular subgroups and models of medulloblastoma

  2012cites this paper
• Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks.

  2012cites this paper
• Cell cycle- and DNA repair pathway-specific effects of apoptosis on tumor suppression

  2012cites this paper
• Personalized mice: modelling the molecular heterogeneity of medulloblastoma

  2012cites this paper
• Mouse models of medulloblastoma

  2011cites this paper
• Opposite modifying effects of HR and NHEJ deficiency on cancer risk in Ptc1 heterozygous mouse cerebellum

  2011cites this paper
• Genomic Characterization of Medulloblastoma

  2011cites this paper
• The C. elegans p53 Family Gene cep-1 and The Nondisjunction Gene him-5 Are Required for Meiotic Recombination

  2011cites this paper
• Maternal intake of folic acid and neural crest stem cells.

  2011cites this paper
• Cerebellum development and medulloblastoma.

  2011cites this paper
• Generation and analysis of mouse models of aberrant β-catenin function

  2011cites this paper
• Mechanisms that promote and suppress chromosomal translocations in lymphocytes.

  2011cites this paper
• Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients

  2010cites this paper
• Targeted Therapy in Medulloblastoma in Molecularly Targeted Therapy for Childhood Cancer

  2010cites this paper
• The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers.

  2010cites this paper
• Telomere maintenance as therapeutic target in embryonal tumours.

  2010cites this paper
• ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells

  2010cites this paper
• Chromosomal location targets different MYC family gene members for oncogenic translocations

  2009cites this paper
• Cerebellar granule cells: insights into proliferation, differentiation, and role in medulloblastoma pathogenesis.

  2009cites this paper
• Medulloblastoma: role of developmental pathways, DNA repair signaling, and other players.

  2009cites this paper
• Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency

  2009influential citation
• N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma.

  2009cites this paper
• medulloblastoma N-myc alters the fate of preneoplastic cells in a mouse model of Material Supplemental

  2009cites this paper
• Mouse models of CNS embryonal tumors

  2009cites this paper
• Role of mammalian Mre11 in classical and alternative non-homologous end joining

  2009cites this paper
• N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma

  2009cites this paper
• The Genomic Basis of Breast Development and Differentiation

  2009cites this paper
• SCID Dogs: Similar Transplant Potential but Distinct Intra-Uterine Growth Defects and Premature Replicative Senescence Compared with SCID Mice1

  2009cites this paper
• Mouse Models of DNA Double Strand Break Repair Deficiency and Cancer

  2009cites this paper
• Two Tumor Suppressors, p27Kip1 and Patched-1, Collaborate to Prevent Medulloblastoma

  2009cites this paper
• Transcriptome Profile and Cytogenetic Analysis of Immortalized Neuronally Restricted Progenitor Cells Derived from the Porcine Olfactory Bulb

  2009cites this paper
• Investigating the Fate of Pre-neoplastic Cells in a Mouse Model of Medulloblastoma

  2009cites this paper
• DNA-PK: the means to justify the ends?

  2008cites this paper
• H2ax/p53-deficient thymic lymphomas with clonal translocations Aberrant V(D)J recombination is not required for rapid development of

  2008cites this paper
• The origins of medulloblastoma subtypes.

  2008cites this paper
• Pathological and molecular heterogeneity of medulloblastoma

  2008cites this paper
• Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.

  2008cites this paper
• The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.

  2008cites this paper
• Cancer stem cells and survival pathways

  2008cites this paper
• Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

  2008cites this paper